Company intelligence
Concord Health Partners
We invest in companies with innovative technologies and solutions that advance healthcare.
About Concord Health Partners
Concord Health Partners is a healthcare focused investment firm with deep industry knowledge including a team of investment professionals with extensive experience in healthcare. We invest in innovative companies that address cost, quality and access to care. Our strategic partnership model aligns interests across all related parties.
Verified activity
Signals from Concord Health Partners
6 published signals
Showing the latest saved company activity while the live feed reconnects.
Partnerships
Concord Health Partners continued its partnership with Thyme Care to support the company's expansion of its platform with innovative services and solutions advancing cancer care.
Reported by Concord Health Partners
Capital & Finance
Concord Health Partners announced that Thyme Care closed a $125 million Series E funding round.
Reported by Concord Health Partners
Products & Services
Concord Health Partners secured a $125M Series E funding round for Thyme Care and launched Thyme Companies as a new platform to take the oncology model into new problems.
Reported by George Hoffmann
Capital & Finance
Concord Health Partners announced that Thyme Care built a remote care team that supports patients outside their treating oncologist's own practice, a risk model that measures and manages spend, and a structure that allows oncologists to share in value-based care.
Reported by George Hoffmann
Capital & Finance
Concord Health Partners is raising $90 million Series C funding through a partnership with Scan.com to expand its diagnostic imaging network.
Reported by Concord Health Partners
Partnerships
Concord Health Partners announced a partnership with Charlie Bullock, Oliver Knight, and the Scan.com team to build a category-defining platform in U.S. medical imaging.
Reported by George Hoffmann